DOI QR코드

DOI QR Code

Modulation of obesity by Gyeongshingangjeehwan18 in ob/ob mice

Ob/Ob 마우스에서 경신강지환(輕身降脂丸)18의 비만조절

  • Yoon, Ki-Hyeon (Dept. of Formula Science, College of Oriental Medicine and Research Institute of Oriental Medicine, Dongeui University) ;
  • Lee, Hee-Young (Dept. of Formula Science, College of Oriental Medicine and Research Institute of Oriental Medicine, Dongeui University) ;
  • Jung, Yang-Sam (Dept. of Formula Science, College of Oriental Medicine and Research Institute of Oriental Medicine, Dongeui University) ;
  • Seo, Bu-Il (Department of Oriental Herbology, Daegu Haany University) ;
  • Park, Gyu-Ryeol (Department of Oriental Herbology, Daegu Haany University) ;
  • Yoon, Mi-Chung (Dept. of Life Sciences, Mokwon University) ;
  • Shin, Soon-Shik (Dept. of Formula Science, College of Oriental Medicine and Research Institute of Oriental Medicine, Dongeui University)
  • 윤기현 (동의대학교 한의학과 방제학교실 & 한의학연구소) ;
  • 이희영 (동의대학교 한의학과 방제학교실 & 한의학연구소) ;
  • 정양삼 (동의대학교 한의학과 방제학교실 & 한의학연구소) ;
  • 서부일 (대구한의대학교 한의학과 본초학교실) ;
  • 박규열 (대구한의대학교 한의학과 본초학교실) ;
  • 윤미정 (목원대학교 바이오건강학부) ;
  • 신순식 (동의대학교 한의학과 방제학교실 & 한의학연구소)
  • Received : 2010.08.05
  • Accepted : 2010.09.13
  • Published : 2010.09.30

Abstract

Objectives : This study was undertaken to verify the effects of Gyeongshingangjeehwan18 (GGEx18) on obesity using ob/ob male mice. Methods : Eight-week old mice (wild-type C57BL/6J and ob/ob) were used for all experiments. Wild-type C57BL/6J mice were used as lean control and obese ob/ob mice were randomly divided into 5 groups: obese control, GGEx15, GGEx16, GGEx17, and GGEx18. After mice were treated with several kinds of GGEx for 11 weeks, body weight gain, feeding efficiency ratio, plasma lipid and glucose metabolism. Results : 1. Compared with obese controls, GGEx-treated mice had lower body weight gain and feeding efficiency ratio, the magnitudes of which were prominent in GGEx16 and GGEx18. 2. Consistent with their effects on body weight gain, GGEx16 and GGEx18 not only decreased plasma triglycerides levels, but also increased HDL-cholesterol concentration. 3. CT analysis revealed that visceral fat areas were decreased in all treatment groups compared with obese control mice. The decrease in visceral fat area was prominent in GGEx16 and GGEx18, although they were not statistically significant. 4. The size of adipocytes were significantly decreased by GGEx18, whereas the adipocyte number per unit area was significantly increased, suggesting that GGEx18 decreased the number of large adipocytes. Hepatic lipid accumulation was decreased by GGEx16 and GGEx18, and the inhibitory effect was most effective in GGEx18. 5. Plasma GOT and GPT concentrations were significantly lower following GGEx16 and GGEx18 treatment compared with obese controls. Organ weights were not changed by GGEx treatment, indicating GGEx do not show any toxic effects. Conclusions : These results suggest that GGEx may regulate obesity. Of the 4 compositions, GGEx18 seems to be most effective in improving obesity and lipid disorders.

Keywords

References

  1. Kopelman PG. Obesity as a medical problem. Nature. 2000 Apr 6;404(6778):635-43.
  2. 國家中醫藥管理局 中華本草 編委會 編. 中華本草 (2冊). 第1版 第1次印刷. 上海:上海科學技術出版社, 1999:349-354.國家中醫藥管理局
  3. 沈映君 主編. 中藥藥理學. 第1版 第1次印刷. 北京:人民衛生出版社, 2000:111-115.
  4. 임경아․박용구․조여원. 고지방식이를 섭취한 흰쥐에서 마황의 메탄올 추출물이 체지방조직 세포에 미치는 영향. 大韓韓醫學會誌 2001;22(3):74-80.
  5. 신동준, 김달래, 김선형. 태음조위탕과 마황이 비만백서의 leptin에 미치는 영향. 사상의학회지 2001;13(1):79-87.
  6. van der Hooft CS, Stricker BH. Ephedrine and ephedra in weight loss products and other preparations. Ned Tijdschr Geneeskd. 2002 Jul 13;146(28):1335-1336. Dutch.
  7. Shekelle PG, Hardy ML, Morton SC, Maglione M, Mojica WA, Suttorp MJ, Rhodes SL, Jungvig L, Gagné J. Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance;a meta-analysis. JAMA. 2003 Mar 26;289(12):1537-1545. Epub 2003 Mar 10. https://doi.org/10.1001/jama.289.12.1537
  8. Greenway FL, De Jonge L, Blanchard D, Frisard M, Smith SR. Effect of a dietary herbal supplement containing caffeine and ephedra on weight, metabolic rate, and body composition. Obes Res. 2004 Jul;12(7):1152-1157. https://doi.org/10.1038/oby.2004.144
  9. 이영준․이명종. 마황이 비만쥐의 혈중지질 및 골격근 내의 지방산 대사에 미치는 영향. 韓方再活醫學科學會誌 2005;15(3):99-111.
  10. Food and Drug Administration(FDA), Department of Health and Human Services(HHS). Final Rule Declaring Dietary Supplements Containing Ephedrine Alkaloids Adulterated Because They Present an Unreasonable Risk. 2004:4-17.
  11. 國家中醫藥管理局 中華本草編委會 編. 中華本草(1冊). 第1版 第1次印刷. 上海:上海科學技術出版社, 1999:453-459.
  12. 王浴生․鄧文龍․薛春生 主編. 中藥藥理與應用. 第2版 第3 次印刷. 北京:人民衛生出版社, 2000:684-688.
  13. Keithley J, Swanson B. Glucomannan and obesity; a critical review. Altern Ther Health Med. 2005 Nov-Dec;11(6):30-34.
  14. Cairella M, Marchini G. Evaluation of the action of glucomannan on metabolic parameters and on the sensation of satiation in overweight and obese patients. Clin Ter. 1995 Apr;146(4):269-274.
  15. Vita PM, Restelli A, Caspani P, Klinger R. Chronic use of glucomannan in the dietary treatment of severe obesity. Minerva Med. 1992 Mar;83(3):135-139.
  16. Walsh DE, Yaghoubian V, Behforooz A. Effect of glucomannan on obese patients: a clinical study. Int J Obes. 1984;8(4):289-293.
  17. 오창호. 비만억제자인 $\alpha$ - MSH 유사체의 합성 및 약효분석 (신약개발연구개발사업 최종보고서). 서울:보건복지부, 2003:21.
  18. Garrido-Polonio C, Garcia-Linares MC, Garcia-Arias MT, Lopez-Varela S, Garcia-Fernandez MC, Terpstra AH, Sanchez-Muniz FJ., Thermally oxidised sunflower-seed oil increases liver and serum peroxidation and modifies lipoprotein composition in rats. Br J Nutr. 2004 Aug;92(2):257-265. https://doi.org/10.1079/BJN20041174
  19. 元瓚煜. 고지방식 수컷 마우스 비만모델을 이용한 麻黃과 魔芋의 비만조절효과. 동의대학교대학원. 한의학석사학위논문. 2008:9-28.

Cited by

  1. 경신강지환(輕身降脂丸)18의 분자생물학적인 비만조절 기전에 관한 연구 vol.26, pp.1, 2010, https://doi.org/10.6116/kjh.2011.26.1.065